Vice President & GFH, Biologics

AstraZeneca • Gaithersburg, MD

2d

About The Position

AstraZeneca follows the science to deliver lifechanging medicines. Within Respiratory & Immunology, our biologics portfolio is a critical growth pillar. By executing with everyday excellence and a challenger mindset, we will continue leading in severe eosinophilic asthma, deliver best in class launches in rare eosinophilic diseases and continue redefining care to drive a higher ambition for better outcomes for patients with eosinophilic inflammation driven diseases, securing accelerated growth across priority markets. The Vice President and GFH, Biologics is the enterprise leader for the Biologics franchise (marketed and near launch LCM) across strategy, execution, and capability building. The role sets the global vision and translates it into measurable market impact—owning Franchise commercial and R&D strategy, brand P&L stewardship, LCM launches, geographic expansion, global advocacy, Life Cycle Management and AI enabled go to market models. The VP also leads the franchise that its responsible for Clinical, Regulatory and Operations securing Biologics program development and overall scientific value proposition. The VP also influences Medical, Policy & Patient Advocacy, Market Access, and Market Companies and Regions to deliver sustained practice change and superior patient outcomes. This role will drive the Biologics Franchise to become a multi-blockbuster brand and benefiting more than 400,000 patients WW by 2030 by strengthening severe eosinophilic asthma leadership by evolving Biologics positioning based on latest scientific evidence, accelerating launch uptake and market development in key geographies like China and International region, delivering Biologics LCM program in HES and paediatric studies, and delivering best in class LCM launches in both EGPA and HES securing a halo at Franchise level ensuring portfolio optimised Go to Market Models.

Requirements

• BA/BS in Business, Life Sciences or related field.
• 18+ years in biopharma commercial roles with sustained global leadership experience; track record of delivering P&L or enterprise level outcomes across multiple regions.
• Deep Respiratory/immunology experience or adjacent expertise with proven ability to rapidly master respiratory biologics markets.
• Demonstrated success leading large, complex, cross functional global programs, including launches and lifecycle management in highly competitive categories.
• Evidence of converting advocacy and guidelines into measurable practice change at scale
• Proven design and execution of go to market models in priority markets, including USA, Japan, China and International markets; experience with tender/nVBP, IRP, and post LoE strategies.
• Strong command of market access and pricing, regulatory interfaces, and evidence needs to shape TPPs and submissions.
• Demonstrated excellence in AI enabled commercial execution (NBAs, journey orchestration, field coaching) and data driven measurement.
• Outstanding executive communication and influence with senior stakeholders, KEEs, and policy bodies; success operating across R&D, Medical, Access, and Operations.
• People leader with a track record of building high performing, diverse teams and developing successors.

Nice To Haves

• Advanced degree (MBA, MSc, or PhD) in life sciences or business.
• Experience overseeing or actively participating in R&D operations at Global or Asia level.
• Established global relationships with respiratory experts, professional societies, and advocacy groups.

Responsibilities

• Strategic Leadership, Geographic Expansion and Portfolio Stewardship
• Financial and Operational Ownership
• Accelerate Brand Growth underpinned with Advocacy, access and Evidence Generation
• Drive R&D Biologics Franchise program
• Market Access, Pricing, and Risk Management
• AI Enabled Commercial Excellence and Measurement
• External Leadership and Partnerships
• People and Culture
• Drive Biologics Franchise to become a multi-blockbuster brand and benefiting more than 400,000 patients WW by 2030 by: Strengthening severe eosinophilic asthma leadership by evolving Biologics positioning based on latest scientific evidence
• Accelerate launch uptake and market development in key geographies like China and International region
• Deliver Biologics LCM program in HES and paediatric studies
• Deliver best in class LCM launches in both EGPA and HES securing a halo at Franchise level ensuring portfolio optimised Go to Market Models

Benefits

• a qualified retirement program [401(k) plan]
• paid vacation
• paid holidays
• paid leaves
• health benefits including medical, prescription drug, dental, and vision coverage
• short-term incentive bonus opportunity
• eligibility to participate in our equity-based long-term incentive program (salaried roles)
• retirement contribution (hourly roles)
• commission payment eligibility (sales roles)

What This Job Offers

• Job Type: Full-time
• Career Level: Executive
• Number of Employees: 5,001-10,000 employees